Prevention of peripheral side-effects of transdermal hyoscine by adjunctive therapy with low dosage of pyridostigmine.
Ziv, I
Prevention of peripheral side-effects of transdermal hyoscine by adjunctive therapy with low dosage of pyridostigmine. [electronic resource] - British journal of clinical pharmacology May 1992 - 507-10 p. digital
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
0306-5251
10.1111/j.1365-2125.1992.tb04078.x doi
Acetylcholinesterase--blood
Administration, Cutaneous
Adolescent
Adult
Delayed-Action Preparations
Double-Blind Method
Drug Therapy, Combination
Humans
Pyridostigmine Bromide--administration & dosage
Salivation--drug effects
Scopolamine--administration & dosage
Tablets
Prevention of peripheral side-effects of transdermal hyoscine by adjunctive therapy with low dosage of pyridostigmine. [electronic resource] - British journal of clinical pharmacology May 1992 - 507-10 p. digital
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
0306-5251
10.1111/j.1365-2125.1992.tb04078.x doi
Acetylcholinesterase--blood
Administration, Cutaneous
Adolescent
Adult
Delayed-Action Preparations
Double-Blind Method
Drug Therapy, Combination
Humans
Pyridostigmine Bromide--administration & dosage
Salivation--drug effects
Scopolamine--administration & dosage
Tablets